Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX), Motorola Solutions Inc (MSI): Jeffrey Ubben’s Top Stock Picks

Jeffrey Ubben’s ValueAct Capital has disclosed its holdings for the second quarter, revealing 16 investments which have a current market value of $13.5 billion. The portfolio remains focused on the tech industry, which makes about 50% of the total, and finance plus healthcare, which together make around 33% of the portfolio. Ubben is a long-term investor and usually does not make more than a few purchases a year. In addition, the investor does not look to be highly diversified, his three top picks make around 55% of the total portfolio value.


The top pick for the quarter is Microsoft Corporation (NASDAQ:MSFT), where the investor has acquired additional 2.9 million shares, taking its stake to 74.2 million shares which have a market value of $3 billion. The Microsoft Corporation (NASDAQ:MSFT) stake makes 22.88% of the total portfolio value. In addition to Ubben, Boykin Curry’s Eagle Capital Management is bullish on Microsoft Corporation (NASDAQ:MSFT) owning 33 million shares worth $1.3 billion.

On the second place there is Canadian Valeant Pharmaceuticals Intl Inc (NYSE:VRX), where Ubben holds a stake of 18 million shares, unchanged from the last quarter. The shares are worth 2.3 billion and make as much as 17.64% of the entire portfolio. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is currently involved together with Bill Ackman’s Pershing Square in a high-profile takeover battle with Allergan, Inc. (NYSE:AGN). Andreas Halvorsen’s Viking Global is bullish on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as well, as it has increased its stake in the last quarter by 2.5 million shares, to 11.8 million. The stake is worth $1.4 billion.

Motorola Solutions Inc (NYSE:MSI) has grabbed the third place in ValueAct’s portfolio, the same as the previous quarter. Jeffrey Ubben owns 28 million shares in the company which have a market value of $1.9 billion. The stake in Motorola Solutions Inc (NYSE:MSI) makes 14.2% of the entire portfolio. Motorola Solutions Inc (NYSE:MSI) is also owned by Leon Cooperman, who holds 2.9 million shares worth $195 million, according to his latest 13F.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!